Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Prospective, Randomized, Open label Controlled trial to evaluate the safety and efficacy of Dexmedetomidine Compared with Midazolam in children admitted to Pediatric Intensive Care unit (PICU) at KAMC-NGHA KAIMRC Rejected Dexmedetomidine (Precedex) 3 RC11/084/R NGHA-R
Prospective, Randomized, open label Controlled trial to evaluate the safety and efficacy of Dexmedetomidine Compared with Midazolam in children admitted to Pediatric Critical Care unit (PICU) at KAMC-NGHA (PROMISE) KAIMRC Rejected Dexmedetomidine 3 RC11/084 NGHA-R
Prospective, Open-label, Uncontrolled, Phase III Study to Assess the Efficacy and Safety of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery in Subjects With Congenital Fibrinogen Deficiency Octapharma Ongoing Octafibrin 3 Forma 02 KKUH
Prophylactic Acetaminophen (Panadol) To Prevent the Intraventricular Haemorrhage of Premature Babies. King Saud Medical City Rejected Acetaminophen 3 HRC-09-Nov15-02 KSMC
Potential Benefits of Black Seed Oil Supplementation on Asthma Inflammation and Outcomes King Abdulaziz University Hospital Completed Black Cumin Oil 2 95-15 KAUH-J
"Postoperative Analgesic Effect of Dexmedetomidine as an Adjunct to Ropivacaine Administration in Wound Infiltration for Modified Radical Mastectomy- A Randomized controlled Trial" King Abdullah Medical City, Makkah Ongoing DEXMEDETOMIDINE 2 14-119 KAMC
Phase IIIb, Randomized Multicentre Comparative Trial to Evaluate the Long Term Effectiveness & Safety of the use of Carbaglu® in Patients with Propionic Acidemia (PA) or Methylmalonic Acidemia (MMA) KAIMRC Ongoing Carglumic acid 3 IIT-OE-2013-001 NGHA-R
Phase III, Single-arm, Open-label, International, Multi-centre Study to Evaluate the Efficacy and Safety of Lomitapide in Paediatric Patients with Homozygous Familial Hypercholesterolaemia (HoFH) on Stable Lipid-lowering Therapy Amryt Pharmaceuticals DAC Ongoing LOMITAPIDE 3 APH-19 King Abdulaziz Medical City NG (Riyadh)
Phase IIb Primary Vaccination Study to Evaluate Non-Inferiority & Persistence of the Immune Response of GSK Biologicals' MenACWY Conjugate Vaccine (Intramuscularly) vs Mencevax ACWY (Subcutaneously) to Healthy Subjects (11-55 Years of Age) Gsk Completed Meningococcal ACWY Conjugate Vaccine 3b 107402 NGHA-R
Phase II/III randomized multicentre study comparing neoadjuvant chemoradiotherapy followed by consolidation chemotherapy to neoadjuvant chemoradiotherapy alone in non-metastatic rectal cancer patients. King Abdullah Medical City, Makkah Ongoing Capecitabine / oxaliplatin / FOLINIC Acid / FLUOROURACIL 2 IRB#17-329 version2 KAMC
View 181 - 190 From 720